You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-Ras-HRS-4642
HRS-4642

Chemical Structure : HRS-4642

CAS No.: 2885261-74-3

HRS-4642 (HRS4642)

Catalog No.: PC-22656Not For Human Use, Lab Use Only.

HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor with SPR KD of 0.083 nM, >20-fold selective over wild-type KRAS and KRAS G12C.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor with SPR KD of 0.083 nM, >20-fold selective over wild-type KRAS and KRAS G12C.
HRS-4642 binds to KRAS G12D in both GDP- and GTP-bound forms.
HRS-4642 selectively inhibits the interaction between GDP-loaded KRAS G12D and SOS1 with IC50 of 0.72 nM.
HRS-4642 inhibits cellular RAS activity in the KRAS G12D-mutant cell line with IC50 of 2.329 nM in AsPC-1 cells, >350-fold selective over PC9 cells.
HRS-4642 selectively hindered the binding of GTP-loaded KRAS G12D to RAF1, a crucial downstream effector of the KRAS signaling pathway with IC50 of 5.9 nM.
HRS-4642 showed dose-dependent inhibition of cellular p-MEK and p-ERK levels in cell lines harboring KRAS G12D mutation.
HRS-4642 exhibited high selectivity in inhibiting the growth of KRAS G12D-mutant cell lines, with IC50 values ranging from 0.55 to 66.58 nM, but not G12C, G12V, G12S, G12A, G13D, and wild type cells.
HRS-4642 (7.5 or 15 mpk) inhibits tumor growth in KRAS G12D-mutant GP2d xenograft model in BALB/c nude mice.

Physicochemical Properties

M.Wt 632.69
Formula C34H35F3N6O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-Naphthalenol, 5-ethyl-6-fluoro-4-[(8aR,9R,12S)-4-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]-8a,9,10,11,12,13-hexahydro-9,12-imino-8H-7-oxa-1,3,6,13a-tetraazanaphtho[1,8-ab]heptalen-5-yl]-

References

1. Zhou C, et al. Cancer Cell. 2024 Jul 8;42(7):1286-1300.e8.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: